IM Cannabis (IMCC) Shares Outstanding (Weighted Average) (2019 - 2026)

IM Cannabis (IMCC) recorded quarterly Shares Outstanding (Weighted Average) of $197544.0 in Q1 2026, up 1.83% quarter-over-quarter from $193984.7 in Q4 2025, and up 6.96% on a YoY basis from $184682.9 in Q1 2025.

IM Cannabis (IMCC) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends

IM Cannabis' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $197544.0 for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 6.96% year-over-year to $197544.0; the TTM figure through Mar 2026 stood at $197544.0 (up 6.96% YoY), while the FY2025 annual figure was $193984.7, down 91.39% from the prior year.
  • Shares Outstanding (Weighted Average) was $197544.0 for Q1 2026 at IM Cannabis, up from $193984.7 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.2 million in Q4 2024 to a low of $0.48 in Q2 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $429495.9 across 5 years, with a median of $190329.5 in 2022.
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) surged 394439119.72% in 2022, then tumbled 99.13% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $929417.1 in 2022, then surged by 76.43% to $1.6 million in 2023, then soared by 34.7% to $2.2 million in 2024, then slumped by 91.22% to $193984.7 in 2025, then grew by 1.83% to $197544.0 in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $197544.0 (Q1 2026), $193984.7 (Q4 2025), and $195881.9 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 IM Cannabis 57,090.22 -728,264.31 1.03 Mn 197,544.01

Historic Data

Download Data
DateValue
Mar 31, 2026 197,544.01
Dec 31, 2025 193,984.75
Sep 30, 2025 195,881.90
Jun 30, 2025 193,291.93
Mar 31, 2025 184,682.87
Dec 31, 2024 2.21 Mn
Sep 30, 2024 1,636.18
Jun 30, 2024 0.48
Mar 31, 2024 188,412.90
Dec 31, 2023 1.64 Mn
Sep 30, 2023 187,344.17
Mar 31, 2023 182,605.88
Dec 31, 2022 929,417.06
Sep 30, 2022 188,007.71
Jun 30, 2022 189,682.59
Mar 31, 2022 190,976.47
Dec 31, 2021 900,653.03
Sep 30, 2021 0.05
Jun 30, 2021 0.08
Mar 31, 2021 0.09